Literature DB >> 18375132

Characterization, phase-solubility, and molecular modeling of inclusion complex of 5-nitroindazole derivative with cyclodextrins.

Carolina Jullian1, Javier Morales-Montecinos, Gerald Zapata-Torres, Benjamín Aguilera, Jorge Rodriguez, Vicente Arán, Claudio Olea-Azar.   

Abstract

The slightly water-soluble 5-nitroindazole derivative (5-NI) and its inclusion with either beta-cyclodextrin (betaCD) or Heptakis (2,6-di-O-methyl)-beta-cyclodextrin (DMbetaCD) were investigated. The stoichiometric ratios and stability constants describing the extent of formation of the complexes were determined by phase-solubility measurements obtaining type-A(L) diagrams in both cases. According to the continuous variation method (Job's plot) a 1:1 stoichiometry has been proposed for the complexes. Also electrochemical studies were carried out on both CDs complexes, where the observed change in the E(PC) value for DMbetaCD indicated a lower feasibility of the nitro group reduction. The detailed spatial configuration is proposed based on two-dimensional NMR methods. These results are further interpreted using molecular modeling studies. The latter results are in good agreement with the experimental data.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375132     DOI: 10.1016/j.bmc.2008.03.026

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Host-guest interaction between herbicide oxadiargyl and hydroxypropyl-β-cyclodextrin.

Authors:  Sofia Benfeito; Tiago Rodrigues; Jorge Garrido; Fernanda Borges; E Manuela Garrido
Journal:  ScientificWorldJournal       Date:  2013-11-25

2.  Enhanced Solubility and Anticancer Potential of Mansonone G By β-Cyclodextrin-Based Host-Guest Complexation: A Computational and Experimental Study.

Authors:  Panupong Mahalapbutr; Piyanuch Wonganan; Thanapon Charoenwongpaiboon; Manchumas Prousoontorn; Warinthorn Chavasiri; Thanyada Rungrotmongkol
Journal:  Biomolecules       Date:  2019-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.